GenScript Biotech, a US-China provider of life science research products, raised $67.6 million in a Hong Kong IPO. GenScript is headquartered in New Jersey, but the company located its major R&D and production facility in Nanjing’s Jiangning Science Park. About half of the company’s business is in the US, and it markets to 100 countries globally.
